> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Web Page on Coronavirus Product Development
- URL: https://www.fdaweb.com/fda-web-page-on-coronavirus-product-development/
- Published: 2020-01-27T12:00:00.000Z
- Updated: 2026-09-14T16:00:00.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5145936

FDA has launched a new [Web page](https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/novel-coronavirus-2019-ncov?ref=fdaweb.com) to help companies advance development of novel coronavirus medical countermeasures. Faced with growing concern about the spreading virus, the agency says it will “collaborate with interagency partners, product developers, international partners and global regulators to expedite the development and availability of medical products needed to diagnose, treat, mitigate and prevent such outbreaks.”

The Web page is intended to offer key information to support the timely development of medical products to respond to the current outbreak, such as information on approval pathways, including Emergency Use Authorization (EUA) for medical countermeasures, including diagnostic tests.

**“**Currently, there are no commercially available products that are authorized to detect novel coronavirus,” an FDA notice says, but it is working with public health partners to advance and share the reference materials necessary to facilitate diagnostic development. Sponsors interested in an EUA for tests to detect the virus should contact CDRH-EUA-Templates@fda.hhs.gov for more information and templates. Sponsors interested in developing therapeutics should submit information and questions to FDA’s [Pre-IND Consultation program](https://www.fda.gov/drugs/investigational-new-drug-ind-application/pre-ind-consultation-program?ref=fdaweb.com).